Hemmersbach-Miller, Marion
Balevic, Stephen J.
Winokur, Patricia L.
Landersdorfer, Cornelia B.
Gu, Kenan
Chan, Austin W.
Cohen-Wolkowiez, Michael
Conrad, Thomas
An, Guohua
Kirkpatrick, Carl M. J.
Swamy, Geeta K.
Walter, Emmanuel B.
Schmader, Kenneth E.
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), US Department of Health and Human Services (HHSN272201500002C)
Vaccine and Treatment Evaluation Units (HHSN272201300017I, HHSN2722013000201)
National Institute of Allergy and Infectious Diseases of the National Institutes of Health (5T32AI100851)
National Institute on Aging, Duke Pepper Older Americans Independence Center (NIA P30AG028716)
National Institutes of Health (1U24-MD016258)
National Institute of Allergy and Infectious Diseases (HHSN272201500006I, HHSN272201300017I, 1K24-AI143971)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (HHSN275201000003I)
U.S. Food and Drug Administration (5U18-FD006298)
Article History
Accepted: 11 December 2022
First Online: 12 January 2023
Declarations
:
: This project has been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, US Department of Health and Human Services, through Contract No. HHSN272201500002C (Emmes), and a Vaccine and Treatment Evaluation Units award under Contract No. HHSN272201300017I (Duke University) and Contract No. HHSN2722013000201 (University of Iowa). This work was also supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (grant number 5T32AI100851 to MHM). KES also received support from the National Institute on Aging, Duke Pepper Older Americans Independence Center, NIA P30AG028716. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. MCW receives support for research from the NIH [1U24-MD016258], National Institute of Allergy and Infectious Diseases [HHSN272201500006I, HHSN272201300017I, 1K24-AI143971], NICHD [HHSN275201000003I], US Food and Drug Administration [5U18-FD006298], and industry for drug development in adults and children.
: SJB receives support from the National Institutes of Health, the US Food and Drug Administration, the Patient-Centered Outcomes Research Institute, the Rheumatology Research Foundation’s Scientist Development Award, the Childhood Arthritis and Rheumatology Research Alliance, Purdue Pharma, and consulting for UCB. The remaining authors have no relevant disclosures.
: The study was reviewed and approved by the institutional review board at the respective study sites.
: Written informed consent was obtained by patients or their legally authorized representative.
: Patients signed informed consent regarding the publishing of their data. They were informed their identity will not be revealed.
: Data are to be made available as widely as possible, while safeguarding the privacy of participants, and protecting confidential and proprietary data.
: Not applicable.
: MH-M: conception and design of the analysis, acquisition, interpretation of data for the work, and revising the work critically for important intellectual content. SJB: conception and design of the analysis, acquisition, interpretation of data for the work, and revising the work critically for important intellectual content. PLW: conception and design of the analysis, acquisition, interpretation of data for the work, and revising the work critically for important intellectual content. CBL: conception and design of the analysis, acquisition, interpretation of data for the work, and revising the work critically for important intellectual content. KG: conception and design of the analysis, acquisition, interpretation of data for the work, and revising the work critically for important intellectual content. AWC: conception and design of the analysis, acquisition, interpretation of data for the work, and revising the work critically for important intellectual content. MC-W: conception and design of the analysis, acquisition, interpretation of data for the work, and revising the work critically for important intellectual content. TC: conception and design of the analysis, acquisition, interpretation of data for the work, and revising the work critically for important intellectual content. GA: conception and design of the analysis, acquisition, interpretation of data for the work, and revising the work critically for important intellectual content. CMJK: conception and design of the analysis, acquisition, interpretation of data for the work, and revising the work critically for important intellectual content. GKS: conception and design of the analysis, acquisition, interpretation of data for the work, and revising the work critically for important intellectual content. EBW: conception and design of the analysis, acquisition, interpretation of data for the work, and revising the work critically for important intellectual content. KES: conception and design of the analysis, acquisition, interpretation of data for the work, and revising the work critically for important intellectual content.